Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | GRB2 | P62993 | 1/20 | 0.38 |
| ▸ | CCKAR | P32238 | 1/20 | 0.37 |
| ▸ | CCKBR | P32239 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31298701 | 0.94 | CPB1 (0.45) | TLR2PTPN1KMT2ACALCRLCPB1 | |
| SCHEMBL31298682 | 0.87 | PTPN1 (0.41) | TLR2PTPN1KMT2AGRB2 | |
| SCHEMBL31298671 | 0.85 | ALB (0.48) | TLR2KMT2ACALCRLCPB1CPB2 | |
| SCHEMBL32670193 | 0.84 | PTPN1 (0.41) | TLR2PTPN1GRB2TPSAB1 | |
| SCHEMBL20530026 | 0.81 | ALB (0.53) | TLR2KMT2A | |
| SCHEMBL19541911 | 0.81 | TLR2 (0.56) | TLR2KMT2ACPB1CPB2TPSAB1 | |
| SCHEMBL22514287 | 0.81 | TLR2 (0.54) | TLR2KMT2ACPB1CPB2TPSAB1 | |
| SCHEMBL19542209 | 0.81 | TLR2 (0.56) | TLR2KMT2ACPB1CPB2TPSAB1 | |
| SCHEMBL30895420 | 0.80 | KMT2A (0.52) | TLR2KMT2A | |
| SCHEMBL29521888 | 0.80 | ALB (0.44) | TLR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025029608-A1 | FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOF | RATIO THERAPEUTICS, INC. (US) | 2025-02-06 | — | — | WO | disclosed |